Pfizer Doses First Patient Using Investigational Mini-Dystrophin … – Business Wire (press release)
Business Wire (press release) |
Pfizer Doses First Patient Using Investigational Mini-Dystrophin …
Business Wire (press release) NEW YORK–(BUSINESS WIRE)–Pfizer Inc. has initiated a Phase 1b clinical trial for its mini-dystrophin gene therapy candidate, PF-06939926, in boys with Duchenne muscular dystrophy (DMD). The first boy received an infusion of the mini-dystrophin gene … Pfizer Begins Clinical Trial With Mini-dystrophin Gene Therapy Candidate Pfizer (PFE) Commences Phase 1b Clinical Trial for Investigational … First Duchenne Patient Dosed in Pfizer's Mini-Dystrophin Study |
